[Manifestations of acute hematogenous osteomyelitis in infants in the change of clinical therapeutic progress with special reference to surgical indication in concurrence with medical therapy with sulfonamide preparations and antibiotics].
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000904:Antibiotics, Antitubercular; D002648:Child; D003879:Dermatologic Agents; D006801:Humans; D007223:Infant; D010019:Osteomyelitis; D000077145:Sulfanilamide; D013424:Sulfanilamides; D013449:Sulfonamides / Q000627:therapeutic use*
D000900:Anti-Bacterial Agents; D000904:Antibiotics, Antitubercular; D003879:Dermatologic Agents; D013424:Sulfanilamides; D013449:Sulfonamides; D000077145:Sulfanilamide
ANTIBIOTICS/therapeutic use; OSTEOMYELITIS/in infant and child; SULFONAMIDES/therapeutic use
Das Krankheitsbild der akuten hämatogenen Säuglingsosteomyelitis im Wandel der klinischen Behandlungsfortschritte unter besonderer Berücksichtigung der operativen Indikation in Konkurrenz mit der medikamentösen Therapie durch Sulfonamidpräparate und Antibiotica.